| Issue |
Title |
File |
| Vol 12, No 3 (2012) |
Curcumin and its Formulations: Potential Anti-Cancer Agents |
(Eng)
|
|
Ji J., Huang X., Zhu H.
|
| Vol 12, No 5 (2012) |
Drug Targeting Strategies for Photodynamic Therapy |
(Eng)
|
|
Schmitt F., Juillerat-Jeanneret L.
|
| Vol 12, No 9 (2012) |
Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules |
(Eng)
|
|
Sarkar S., B. Fisher P., Sarkar D., Pellecchia M., C. Reed J., W. Diaz P., L. Stebbins J., Wu B., Wei J., G. Pomper M., Wang X., Bhoopathi P., E. Menezes M., Erdogan E., Hedvat M., K. Sokhi U., P. Kegelman T., A. Oyesanya R., A. Quinn B., Dash R., Zhu S., Hu B., Thomas S., Dasgupta S., Kim K., K. Das S., Emdad L.
|
| Vol 12, No 8 (2012) |
Pro-apoptotic Activity of BH3-only Proteins and BH3 Mimetics: from Theory to Potential Cancer Therapy |
(Eng)
|
|
L. Hartman M., Czyz M.
|
| Vol 12, No 8 (2012) |
Fig Latex (Ficus carica L. cultivar Dottato) in Combination with UV Irradiation Decreases the Viability of A375 Melanoma Cells In Vitro |
(Eng)
|
|
Menichini G., Alfano C., Provenzano E., Marrelli M., A. Statti G., Somma F., Menichini F., Conforti F.
|
| Vol 12, No 8 (2012) |
CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells |
(Eng)
|
|
Bergamo A., Delfino R., Casarsa C., Sava G.
|
| Vol 12, No 8 (2012) |
Structures Required of Flavonoids for Inhibiting Digestive Enzymes |
(Eng)
|
|
Cao H., Chen X.
|
| Vol 12, No 8 (2012) |
Bovine Serum Albumin Significantly Improves the DPPH Free Radical Scavenging Potential of Dietary Polyphenols and Gallic Acids |
(Eng)
|
|
Cao H., Chen X., Yamamoto K.
|
| Vol 12, No 8 (2012) |
Probing the Interaction of Anti-Cancer Agent Dihydromyricetin with Human Serum Albumin: A typical Method Study |
(Eng)
|
|
Jiang G., Zhu L., Lu T., Chen T., Zhu S., Lu Y., Cao H., Zhao Y.
|
| Vol 12, No 8 (2012) |
Natural-derived Polyphenols as Potential Anticancer Agents |
(Eng)
|
|
Spatafora C., Tringali C.
|
| Vol 12, No 8 (2012) |
Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization |
(Eng)
|
|
Shen M., Hang Chan T., Ping Dou Q.
|
| Vol 12, No 8 (2012) |
Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins |
(Eng)
|
|
Michalak K., Wesolowska O.
|
| Vol 12, No 8 (2012) |
Regulation of Cell Death and Survival by Resveratrol: Implications for Cancer Therapy |
(Eng)
|
|
Fulda S.
|
| Vol 12, No 8 (2012) |
Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents |
(Eng)
|
|
Ghiringhelli F., Rebe C., Hichami A., Delmas D.
|
| Vol 12, No 8 (2012) |
Flavonoids in Cancer Prevention |
(Eng)
|
|
Park E., M. Pezzuto J.
|
| Vol 12, No 8 (2012) |
EDITORIAL (Hot Topic: Natural Polyphenols Properties: Chemopreventive and Chemosensitizing Activities) |
(Eng)
|
|
Delmas D., Xiao J.
|
| Vol 12, No 8 (2012) |
Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer |
(Eng)
|
|
Khosravi-Shahi P., Cabezon-Gutierrez L.
|
| Vol 12, No 8 (2012) |
In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines |
(Eng)
|
|
Bordon E., G. Leon L., Rios-Luci C., C. Lara P., M. Padron J.
|
| Vol 12, No 9 (2012) |
Dual Roles of Sulforaphane in Cancer Treatment |
(Eng)
|
|
Xu T., Ren D., Sun X., Yang G.
|
| Vol 12, No 9 (2012) |
Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents |
(Eng)
|
|
E. Zembower D., Xie Y., Koohang A., J. Kuffel M., M. Ames M., Zhou Y., Mishra R., Aye Mar A., T. Flavin M., Xu Z.
|
| Vol 12, No 9 (2012) |
Anti-cancer Effects of Curcumin on Head and Neck Cancers |
(Eng)
|
|
Gao W., Yu-Wai Chan J., Ignance Wei W., Wong T.
|
| Vol 12, No 9 (2012) |
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation? |
(Eng)
|
|
P. S. Santos F., Verstovsek S.
|
| Vol 12, No 9 (2012) |
Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma |
(Eng)
|
|
Temirak A., Abdulla M., Elhefnawi M.
|
| Vol 12, No 9 (2012) |
Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand? |
(Eng)
|
|
Zhu Z., Shen Z., Xu C.
|
| Vol 12, No 9 (2012) |
Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones |
(Eng)
|
|
Zec M., Srdic-Rajic T., Konic-Ristic A., Todorovic T., Andjelkovic K., Filipovic-Ljeskovic I., Radulovic S.
|
| Vol 12, No 9 (2012) |
Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy |
(Eng)
|
|
Prados J., Melguizo C., Ortiz R., Velez C., J. Alvarez P., L. Arias J., A. Ruiz M., Gallardo V., Aranega A.
|
| Vol 12, No 9 (2012) |
CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation? |
(Eng)
|
|
Gonzalez-Martin A., Mira E., Manes S.
|
| Vol 12, No 9 (2012) |
The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer |
(Eng)
|
|
Kotta-Loizou I., Giaginis C., Theocharis S.
|
| Vol 12, No 9 (2012) |
Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling |
(Eng)
|
|
Reis M., J. Ferreira R., Serly J., Duarte N., M. Madureira A., J. V. A. Santos D., Molnar J., U. Ferreira M.
|
| Vol 12, No 9 (2012) |
The Nuclear Orphan Receptors NR4A as Therapeutic Target in Cancer Therapy |
(Eng)
|
|
J. A. Deutsch A., Angerer H., E. Fuchs T., Neumeister P.
|
| Vol 12, No 8 (2012) |
Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis |
(Eng)
|
|
Wang X., Chen W.
|
| Vol 12, No 7 (2012) |
Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma |
(Eng)
|
|
Yakushijin Y., Tatsukawa T., Yamaguchi T., Egawa T., Hidaka N., Ido K., Suemaru K., Yasukawa M., Araki H.
|
| Vol 12, No 7 (2012) |
Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice |
(Eng)
|
|
Cao Z., Mendoza J., Kozielski A., Liu X., DeJesus A., Wang Y., Zhan C., Vardeman D., Giovanella B.
|
| Vol 12, No 5 (2012) |
Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors |
(Eng)
|
|
Giovacchini G., Nicolas G., Forrer F.
|
| Vol 12, No 6 (2012) |
Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors |
(Eng)
|
|
Park Y., Moriyama A., Kitahara T., Yoshida Y., Urita T., Kato R.
|
| Vol 12, No 6 (2012) |
Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421 |
(Eng)
|
|
Olszewski U., Zeillinger R., Demirel Kars M., Zalatnai A., Molnar J., Hamilton G.
|
| Vol 12, No 6 (2012) |
A New 4-phenyl-1,8-naphthyridine Derivative Affects Carcinoma Cell Proliferation by Impairing Cell Cycle Progression and Inducing Apoptosis |
(Eng)
|
|
Capozzi A., Mantuano E., Matarrese P., Saccomanni G., Manera C., Mattei V., Gambardella L., Malorni W., Sorice M., Misasi R.
|
| Vol 12, No 6 (2012) |
Effects of Bioactive Compounds from Carrots (Daucus carota L.), Polyacetylenes, Beta-Carotene and Lutein on Human Lymphoid Leukaemia Cells |
(Eng)
|
|
G. Zaini R., Brandt K., R. Clench M., L. Le Maitre C.
|
| Vol 12, No 6 (2012) |
The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis |
(Eng)
|
|
Shen T., Huang S.
|
| Vol 12, No 6 (2012) |
Cranberry as Promising Natural Source of Potential Anticancer Agents: Current Evidence and Future Perspectives |
(Eng)
|
|
Katsargyris A., Tampaki E., Giaginis C., Theocharis S.
|
| Vol 12, No 6 (2012) |
Anticancer Activity and Anti-inflammatory Studies of 5-Aryl-1,4-benzodiazepine Derivatives |
(Eng)
|
|
Sandra C., Cortes Eduardo C., Simon H., Apan Teresa R., Camacho Antonio N., V. Lijanova I., Marcos M.
|
| Vol 12, No 6 (2012) |
Gallium Phthalocyanine Photosensitizers: Carboxylation Enhances the Cellular Uptake and Improves the Photodynamic Therapy of Cancers |
(Eng)
|
|
F. Zhao J., Wang J., Chen J., Chidawanykia W., Nyokong T., Ishii K., Kobayashi N.
|
| Vol 12, No 6 (2012) |
Current and Emerging Strategies in Bladder Cancer |
(Eng)
|
|
Carradori S., Cristini C., Secci D., Gulia C., Gentile V., Battista Di Pierro G.
|
| Vol 12, No 6 (2012) |
Anticoagulant and Fibrinolytic Drugs Possible Agents in Treatment of Lung Cancer? |
(Eng)
|
|
Bobek V.
|
| Vol 12, No 6 (2012) |
Neutrophil Elastase as a Target in Lung Cancer |
(Eng)
|
|
Moroy G., J.P. Alix A., Sapi J., Hornebeck W., Bourguet E.
|
| Vol 12, No 5 (2012) |
Genistein Potentiates the Anti-cancer Effects of Gemcitabine in Human Osteosarcoma via the Downregulation of Akt and Nuclear Factor-κB Pathway |
(Eng)
|
|
Liang C., Li H., Shen C., Lai J., Shi Z., Liu B., Tao H.
|
| Vol 12, No 5 (2012) |
Boronated Compounds for Imaging Guided BNCT Applications |
(Eng)
|
|
Geninatti-Crich S., Deagostino A., Toppino A., Alberti D., Venturello P., Aime S.
|
| Vol 12, No 6 (2012) |
Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents |
(Eng)
|
|
Speck-Planche A., V. Kleandrova V., Luan F., Natalia D. S. Cordeiro M.
|
| Vol 12, No 7 (2012) |
PREFACE [Hot Topic: Novel Cancer-Targeting Agents/Application Strategies Developed from MMP Science] |
(Eng)
|
|
Okazaki I.
|
| Vol 12, No 7 (2012) |
Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents |
(Eng)
|
|
A. Toropov A., P. Toropova A., Benfenati E., Gini G., Leszczynska D., Leszczynski J.
|
| Vol 12, No 7 (2012) |
Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition |
(Eng)
|
|
M. Brunel J., Salmi-Smail C., Restouin A., Prebet T., Vey N., Collette Y.
|
| Vol 12, No 7 (2012) |
A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts |
(Eng)
|
|
Kawakami K., Hattori M., Inoue T., Maruyama Y., Ohkanda J., Kato N., Tongu M., Yamada T., Akimoto M., Takenaga K., Sassa T., Suzumiy J., Honma Y.
|
| Vol 12, No 7 (2012) |
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro |
(Eng)
|
|
E. Larsson D., B. Hassan S., Oberg K., Granberg D.
|
| Vol 12, No 7 (2012) |
Regulation of MMPs During Melanoma Progression: From Genetic to Epigenetic |
(Eng)
|
|
Antonicelli F., Vallerand D., Trussardi-Regnier A., Grange F., Hornebeck W., Bernard P.
|
| Vol 12, No 7 (2012) |
MMPs in Ovarian Cancer as Therapeutic Targets |
(Eng)
|
|
Karam A., Dorigo O.
|
| Vol 12, No 7 (2012) |
Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science |
(Eng)
|
|
Okazaki I., Inagaki Y.
|
| Vol 12, No 7 (2012) |
Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers |
(Eng)
|
|
Hida Y., Hamada J.
|
| Vol 12, No 7 (2012) |
Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream |
(Eng)
|
|
Okazaki I., Nabeshima K.
|
| Vol 12, No 7 (2012) |
Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment |
(Eng)
|
|
Stellas D., Patsavoudi E.
|
| Vol 12, No 7 (2012) |
RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review) |
(Eng)
|
|
Nagini S.
|
| Vol 12, No 7 (2012) |
Modulation of MMPs by Cell Surface Integrin Receptor α5β1 |
(Eng)
|
|
Pal S., Kumar Ganguly K., Moulik S., Chatterjee A.
|
| Vol 12, No 7 (2012) |
MicroRNAs in Cancer: Small Molecules, Big Chances |
(Eng)
|
|
Abba M., Mudduluru G., Allgayer H.
|
| Vol 11, No 5 (2011) |
Combination Therapy for the Treatment of Pancreatic Cancer |
(Eng)
|
|
Greenhalf W., Thomas A.
|
| Vol 11, No 5 (2011) |
An Update on Molecular Research of Pancreatic Adenocarcinoma |
(Eng)
|
|
Krautz C., Ruckert F., Saeger H., Pilarsky C., Grutzmann R.
|
| Vol 11, No 5 (2011) |
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Pancreatic Cancer Therapy (Guest Editor: Dr. Felix Ruckert)] |
(Eng)
|
|
Sebens S., Kalthoff H.
|
| Vol 11, No 4 (2011) |
Molecular Mechanisms of Anti-cancer Action of Garlic Compounds in Neuroblastoma |
(Eng)
|
|
Karmakar S., Roy Choudhury S., L. Banik N., K. Ray S.
|
| Vol 11, No 4 (2011) |
Bioactive Sphingolipids in Response to Chemotherapy: A Scope on Leukemias |
(Eng)
|
|
Atakan Ekiz H., Baran Y.
|
| Vol 11, No 4 (2011) |
Cellular Uptake and Organ Accumulation of Amphipolar Metallocorroles with Cytoprotective and Cytotoxic Properties |
(Eng)
|
|
Okun Z., Kupershmidt L., B. H. Youdim M., Gross Z.
|
| Vol 11, No 4 (2011) |
Salen Mn Complexes Mitigate Radiation Injury in Normal Tissues |
(Eng)
|
|
A. Rosenthal R., Fish B., P. Hill R., D. Huffman K., Lazarova Z., Mahmood J., Medhora M., Molthen R., E. Moulder J., T. Sonis S., J. Tofilon P., R. Doctrow S.
|
| Vol 11, No 4 (2011) |
Anti-Cancer Activity of Nitrones and Observations on Mechanism of Action |
(Eng)
|
|
A. Floyd R., K. Chandru H., He T., Towner R.
|
| Vol 11, No 5 (2011) |
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer |
(Eng)
|
|
Rieder S., W. Michalski C., Friess H., Kleeff >.
|
| Vol 11, No 5 (2011) |
Aptamers: Potential Applications to Pancreatic Cancer Therapy |
(Eng)
|
|
L. Rialon K., R. White R.
|
| Vol 11, No 5 (2011) |
Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma |
(Eng)
|
|
H. Muders M.
|
| Vol 11, No 6 (2011) |
Role of Stem Cells in Normal Liver and Cancer |
(Eng)
|
|
Keung Lau C., Fan Yang Z., Tat Fan S.
|
| Vol 11, No 6 (2011) |
microRNA Involvement in Hepatocellular Carcinoma |
(Eng)
|
|
Negrini M., Gramantieri L., Sabbioni S., M. Croce C.
|
| Vol 11, No 6 (2011) |
Molecular Mechanisms of Liver Cancer |
(Eng)
|
|
Pan H., Fu X., Huang W.
|
| Vol 11, No 6 (2011) |
Editorial [Hot Topic: Recent Advances Into the Molecular Mechanisms and Therapeutic Targeting of Hepatocellular Carcinoma (Guest Editors: Dr. Mei-Sze Chua and Li Wang)] |
(Eng)
|
|
Chua M., Wang L.
|
| Vol 11, No 5 (2011) |
Resveratrol and Its Analogues: Promising Antitumor Agents |
(Eng)
|
|
Zhu H.
|
| Vol 11, No 5 (2011) |
Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms |
(Eng)
|
|
J. Zyromski N., B. White P.
|
| Vol 11, No 5 (2011) |
Anti-Angiogenic Agents in Pancreatic Cancer: A Review |
(Eng)
|
|
M. Assifi M., J. Hines O.
|
| Vol 11, No 5 (2011) |
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer from Molecular Signalling to Clinical Trials |
(Eng)
|
|
Falasca M., Selvaggi F., Buus R., Sulpizio S., E. Edling C.
|
| Vol 11, No 5 (2011) |
Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma? |
(Eng)
|
|
G. Hotz H., Hotz B., Buhr H.
|
| Vol 11, No 4 (2011) |
Nitroxides as Cancer Imaging Agents |
(Eng)
|
|
M. Davis R., B. Mitchell J., C. Krishna M.
|
| Vol 11, No 4 (2011) |
Superoxide Dismutase in Redox Biology: The Roles of Superoxide and Hydrogen Peroxide |
(Eng)
|
|
R. Buettner G.
|
| Vol 11, No 4 (2011) |
A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon |
(Eng)
|
|
Batinic-Haberle I., Rajic Z., Benov L.
|
| Vol 11, No 2 (2011) |
The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies |
(Eng)
|
|
J. Driscoll J., Minter A., A. Driscoll D., K. Burris J.
|
| Vol 11, No 2 (2011) |
The Potential of Zn(II) N-Alkylpyridylporphyrins for Anticancer Therapy |
(Eng)
|
|
Benov L., Craik J., Batinic-Haberle I.
|
| Vol 11, No 2 (2011) |
Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins |
(Eng)
|
|
F. Arambula J., Preihs C., Borthwick D., Magda D., L. Sessler J.
|
| Vol 11, No 2 (2011) |
Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress |
(Eng)
|
|
Verrax J., Beck R., Dejeans N., Glorieux C., Sid B., C. Pedrosa R., Benites J., Vasquez D., A. Valderrama J., Buc Calderon P.
|
| Vol 11, No 2 (2011) |
Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors |
(Eng)
|
|
T. Keir S., W. Dewhirst M., P. Kirkpatrick J., D. Bigner D., Batinic-Haberle I.
|
| Vol 11, No 2 (2011) |
Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis |
(Eng)
|
|
Hempel N., M. Carrico P., Melendez J.A.
|
| Vol 11, No 2 (2011) |
Mitochondrial Superoxide Dismutase - Signals of Distinction |
(Eng)
|
|
Miriyala S., K. Holley A., St Clair D.K.
|
| Vol 11, No 2 (2011) |
Does More MnSOD Mean More Hydrogen Peroxide? |
(Eng)
|
|
Ann MacMillan-Crow L., P. Crow J.
|
| Vol 11, No 2 (2011) |
Superoxide Dismutases: Anti- Versus Pro- Oxidants? |
(Eng)
|
|
Fridovich I.
|
| Vol 11, No 3 (2011) |
Editorial [Hot Topic: Prospective Clinical Role for Anticancer Garlic Organosulfur Compounds (Guest Editor: Hassan T. Hassan)] |
(Eng)
|
|
T. Hassan H.
|
| Vol 11, No 3 (2011) |
Anticancer Effects of Garlic and Garlic-derived Compounds for Breast Cancer Control |
(Eng)
|
|
Tsubura A., Lai Y., Kuwata M., Uehara N., Yoshizawa K.
|
| Vol 11, No 4 (2011) |
Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer:Pro- vs Anti-Oxidative Mode of Action-Part II (Guest Editor: Ines Batinic-Haberle)] |
(Eng)
|
|
Batinic-Haberle I.
|
| Vol 11, No 3 (2011) |
Lenalidomide Current Understanding of Mechanistic Properties |
(Eng)
|
|
Tageja N.
|
| Vol 11, No 3 (2011) |
Astemizole: an Old Anti-histamine as a New Promising Anti-cancer Drug |
(Eng)
|
|
Garcia-Quiroz J., Camacho J.
|
| Vol 11, No 3 (2011) |
Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions |
(Eng)
|
|
Ansari J., A Hussain S., Alhasso A., Mahmood R., Ansari A., Glaholm J.
|
| 901 - 1000 of 1156 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 > >>
|
